OCC Promises to Publish Final Rules on GENIUS by November

cryptonews.ruОпубліковано о 2026-08-19Востаннє оновлено о 2026-08-19

Анотація

The U.S. Comptroller of the Currency, Jonathan Gould, stated that his agency will publish final rules for implementing the GENIUS Act, the stablecoin payments law, by November. Speaking at the Wyoming Blockchain Symposium, Gould noted that the OCC reviewed industry feedback on the proposed rules released in February. He expects the regulator to begin processing applications from stablecoin issuers in 2027. The GENIUS Act, signed in July 2025, aims to establish a U.S. regulatory framework for payment stablecoins and requires several federal agencies, including the OCC, Treasury, FDIC, and Federal Reserve, to develop corresponding rules. While multiple regulators have released proposals and gathered public comments, they have not published final rules yet, creating regulatory uncertainty for issuers ahead of the law's effective date in January 2027.

The U.S. Comptroller of the Currency, Jonathan Gould, stated that his agency will publish the final rules for implementing the stablecoin payments law by November.

Speaking at the Wyoming Blockchain Symposium on Wednesday, the regulator announced that after the Office of the Comptroller of the Currency (OCC) published the proposed rules for implementing the U.S. Stablecoin Guidelines and National Innovation Act ($GENIUS), the OCC will publish the final rules before the law takes effect in January 2027.

Gould stated that the OCC "will publish the final rule by November," as the agency considered feedback from the cryptocurrency industry after publishing the proposed rules in February. He added that he expects the regulator to begin processing applications from stablecoin issuers in 2027.

The $GENIUS Act, signed in July 2025, aims to create a regulatory framework for payment stablecoins in the United States and requires the government agencies overseeing these products, including the OCC, the Department of the Treasury, the Federal Deposit Insurance Corporation (FDIC), and the Board of Governors of the Federal Reserve, to develop appropriate regulations.

In February, the OCC published a 376-page proposed rule for implementing the $GENIUS Act. Government agencies have only until January 18, when the law takes effect, to complete the rulemaking process. Several regulators have already published proposals and gathered public feedback regarding the implementation of $GENIUS but have not published final rules by July, creating regulatory uncertainty for stablecoin issuers.

Related: OCC Approves Trump Family Cryptocurrency Company for Trust Charter

end-content

Трендові криптовалюти

Пов'язані питання

QWhat did the U.S. Comptroller of the Currency promise regarding the rules for the GENIUS Act?

AThe U.S. Comptroller of the Currency, Jonathan Gould, promised that the OCC will publish the final rules for implementing the GENIUS Act by November.

QWhat is the GENIUS Act, and what does it aim to do?

AThe GENIUS Act, signed into law in July 2025, is a U.S. law aimed at creating a regulatory framework for payment stablecoins. It mandates relevant government agencies to develop rules for overseeing these products.

QBy when must government agencies complete their rulemaking for the GENIUS Act?

AGovernment agencies must complete their rulemaking by January 18, 2027, which is when the GENIUS Act takes effect.

QWhat was the outcome of the OCC's publication of the proposed GENIUS Act rules in February?

AFollowing the publication of the proposed 376-page rules in February, the OCC received feedback from the cryptocurrency industry, which it has been considering before publishing the final rules.

QWhen does Jonathan Gould expect the OCC to start processing stablecoin issuer applications?

AJonathan Gould expects that the OCC will be able to start processing applications from stablecoin issuers in 2027.

Пов'язані матеріали

Haiwei Huaxin's Official Seal Seized by Over a Hundred People, High-Stakes Corporate Battle's 'Nuclear Deterrence' in Action Again

On August 18th, Haowei Huaxin, a semiconductor firm specializing in gallium arsenide and gallium nitride wafers, reported that over a hundred individuals forcibly entered its offices and seized the company's official seals from a safe, including the corporate, contract, and party committee seals. The incident is the latest escalation in a protracted control dispute. Haowei Huaxin, established in 2010, was originally a joint venture. Control became contested after 2021 when Zhenwei Financial Holding injected capital, becoming the largest shareholder (34.01%), while former parent Haite High-Tech's stake was diluted to 33.79%. An agreed-upon governance structure collapsed, leading to mutual accusations. Haite claimed it was locked out of the subsidiary's premises, while also alleging improper management like livestock being kept on the chip fabrication site. After state-owned Qingdao Haiyue Holdings took over Zhenwei's stake in 2023, Haite accused it of illegally seizing control. Despite Haite winning several legal battles in 2024-2026, which affirmed its rights to nominate directors and the chairman, it failed to regain physical control or recover the seals. The stakes are high: market valuations for Haite's stake in Haowei Huaxin are estimated between 3.7 to 5 billion USD, yet it is only valued at about 83 million USD on Haite's books. Losing control effectively jeopardizes a significant portion of Haite's value. In response to the seal seizure, Haite framed it as a "shareholder rights protection" action agreed upon by five shareholders. This mirrors a pattern in Chinese corporate disputes where seizing physical seals becomes a tactic to paralyze the opponent's daily operations, seen in past conflicts at companies like Dangdang and Bitmain. However, such actions don't resolve underlying ownership issues; the opposing party can report the seals stolen, declare them void, and apply for new ones, albeit with significant delay. The incident underscores how fragile corporate governance can devolve into physical confrontations over symbols of authority, with control ultimately determined by law and shareholding, not possession of a seal.

marsbit32 хв тому

Haiwei Huaxin's Official Seal Seized by Over a Hundred People, High-Stakes Corporate Battle's 'Nuclear Deterrence' in Action Again

marsbit32 хв тому

Bernstein Interprets MRNA's 177% Surge: What's Fundamentals and What's Hype?

Bernstein's analysis of Moderna's 177% stock surge following positive Phase 3 results for its individualized neoantigen therapy (INT) in melanoma distinguishes fundamental drivers from market speculation. The clinical breakthrough is real: the INTerpath-001 trial met its primary and key secondary endpoints, providing crucial validation for mRNA technology in oncology beyond infectious diseases. However, Bernstein argues the magnitude of the stock move cannot be justified by this single trial's fundamentals alone. The surge was amplified by three key factors: 1) A re-rating of Moderna's mRNA platform potential for expansion into other cancers, 2) A massive short squeeze, given ~15% of shares were sold short pre-announcement, and 3) The compelling "cancer vaccine" narrative that fueled broader investor enthusiasm. While the melanoma success is significant, Bernstein cautions that replication in lung, kidney, and bladder cancers—which have different immunogenicity—is not guaranteed. Furthermore, INT's commercial model faces challenges: it's a personalized treatment, not a mass-market vaccine, implying higher production costs and potential margin pressures despite a projected multi-billion dollar peak sales opportunity. The report also notes sector rotation, with some funds moving from crowded AI/semiconductor trades into defensive healthcare stocks, adding further momentum. In conclusion, Bernstein maintains a "Market-Perform" rating and a $45 price target, far below the post-surge price. It views the current valuation as pricing in an optimistic multi-cancer platform success and efficient commercialization that are yet to be proven. The clinical inflection point is clear, but the earnings inflection point awaits validation across future trials and commercial execution.

marsbit32 хв тому

Bernstein Interprets MRNA's 177% Surge: What's Fundamentals and What's Hype?

marsbit32 хв тому

Торгівля

Спот

Популярні статті

Як купити GENIUS

Ласкаво просимо до HTX.com! Ми зробили покупку Genius (GENIUS) простою та зручною. Дотримуйтесь нашої покрокової інструкції, щоб розпочати свою криптовалютну подорож.Крок 1: Створіть обліковий запис на HTXВикористовуйте свою електронну пошту або номер телефону, щоб зареєструвати обліковий запис на HTX безплатно. Пройдіть безпроблемну реєстрацію й отримайте доступ до всіх функцій.ЗареєструватисьКрок 2: Перейдіть до розділу Купити крипту і виберіть спосіб оплатиКредитна/дебетова картка: використовуйте вашу картку Visa або Mastercard, щоб миттєво купити Genius (GENIUS).Баланс: використовуйте кошти з балансу вашого рахунку HTX для безперешкодної торгівлі.Треті особи: ми додали популярні способи оплати, такі як Google Pay та Apple Pay, щоб підвищити зручність.P2P: Торгуйте безпосередньо з іншими користувачами на HTX.Позабіржова торгівля (OTC): ми пропонуємо індивідуальні послуги та конкурентні обмінні курси для трейдерів.Крок 3: Зберігайте свої Genius (GENIUS)Після придбання Genius (GENIUS) збережіть його у своєму обліковому записі на HTX. Крім того, ви можете відправити його в інше місце за допомогою блокчейн-переказу або використовувати його для торгівлі іншими криптовалютами.Крок 4: Торгівля Genius (GENIUS)Легко торгуйте Genius (GENIUS) на спотовому ринку HTX. Просто увійдіть до свого облікового запису, виберіть торгову пару, укладайте угоди та спостерігайте за ними в режимі реального часу. Ми пропонуємо зручний досвід як для початківців, так і для досвідчених трейдерів.

678 переглядів усьогоОпубліковано 2026.04.29Оновлено 2026.06.02

Як купити GENIUS

Обговорення

Ласкаво просимо до спільноти HTX. Тут ви можете бути в курсі останніх подій розвитку платформи та отримати доступ до професійної ринкової інформації. Нижче представлені думки користувачів щодо ціни GENIUS (GENIUS).

活动图片